P Wahlqvist - Concepedia

Author

P Wahlqvist

AstraZeneca (Sweden)

Also Known As

P WAHLQVIST, P Wahlqvist, P. WAHLQVIST, P. Wahlqvist, PETER WAHLQVIST, Peter Wahlqvist

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (Sweden)AstraZeneca (United Kingdom)Uppsala University Eastern Virginia Medical School University at Buffalo, State University of New York

About

P Wahlqvist is an author at AstraZeneca (Sweden) specializing in gastroenterology, medicine, and quality of life.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Gastroenterology	6	6	296
2	Medicine	5	5	148
3	Health Policy	2	2	182
4	Health Sciences	1	1	12
5	Emergency Medicine	1	1	11

P Wahlqvist

Publications

721

Citations

H-Index

Page 1

	Year	Citations
Validity of a Work Productivity and Activity Impairment Questionnaire for Patients with Symptoms of Gastro-Esophageal Reflux Disease (WPAI-GERD)—Results from a Cross-Sectional Study P Wahlqvist, Jonas Carlsson, Nils‐Olov Stålhammar, Value in Health ProductivityQuality Of LifeHealth PolicyWork ProductivityGastroenterology	2002	148
Relationship between symptom load of gastro‐oesophageal reflux disease and health‐related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort P Wahlqvist, Markus Karlsson, David A. Johnson, Alimentary Pharmacology & Therapeutics	2008	106
Symptoms of gastroesophageal reflux disease, perceived productivity, and health-related quality of life P Wahlqvist The American Journal of Gastroenterology	2001	89
Cost of gastro‐oesophageal reflux disease to the employer: a perspective from the United States RA Brook, P Wahlqvist, Nathan L. Kleinman, Alimentary Pharmacology & Therapeutics	2007	80
Cost Effectiveness of Proton Pump Inhibitors in Gastro-Oesophageal Reflux Disease Without Oesophagitis P Wahlqvist, Ola Junghard, Andy Higgins, PharmacoEconomics EsophagusEsophageal CancerProton Pump InhibitorsGastroenterologySurgery	2002	53
The Burden of Disrupting Gastro-Oesophageal Reflux Disease Samira Toghanian, P Wahlqvist, David A. Johnson, Clinical Drug Investigation EsophagusPatient SafetyGastroenterologyUpper Gastrointestinal SurgeryGastro-oesophageal Reflux Disease	2010	38
Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France Stanislas Bruley des Varannes, Helena Granstedt Löfman, Maria Karlsson, BMC Gastroenterology	2013	35
The Work Productivity and Activity Impairment Questionnaire for Patients with Gastroesophageal Reflux Disease (WPAI-GERD) P Wahlqvist, Gordon Guyatt, David Armstrong, PharmacoEconomics ProductivityQuality Of LifeOccupational ErgonomicsHealth PolicyWork Productivity	2007	34
Objective Measurement of Work Absence and On-The-Job Productivity: A Case-Control Study of US Employees With and Without Gastroesophageal Reflux Disease P Wahlqvist, Richard A. Brook, Sara M. Campbell, Journal of Occupational and Environmental Medicine	2008	34
The impact of illness in patients with moderate to severe gastro-esophageal reflux disease Samer El-Dika, Gordon Guyatt, David Armstrong, BMC Gastroenterology	2005	29

Page 1